MentionFox
Home › Stakes › SOPHiA GENETICS SA
5%+ stakes · Schedule 13D and 13G

SOPHiA GENETICS SA: 5%+ holders

Before you sign with, sell to or invest in SOPHiA GENETICS SA

MentionFox check on SOPHiA GENETICS SA: only 2 sources on file so far (checked 13 November 2026). Run a full check before you rely on it. mentionfox.com/c/stakes/sophia-genetics-sa

Check SOPHiA GENETICS SA before you sign, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about SOPHiA GENETICS SA?

Who has reported owning 5% or more of SOPHiA GENETICS SA, from Schedule 13D and 13G filings: each holder's stake as filed, the timeline, and the purpose each 13D states, quoted.

As of November 13, 2026, one holder's latest Schedule 13D or 13G filing report owning 5% or more of SOPHiA GENETICS SA. The largest reported stake is Schindel Yair Chaim's, at 6.2%. 2 filings are on record since February 11, 2026 (Schedule 13D/A, November 12, 2026).

Sell to companies like SOPHiA GENETICS SA? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

At 5% or more1
Filings2
Latest filing2026-11-12

SOPHiA GENETICS SA has 2 Schedule 13D or 13G filings on record since 2026-02-11. 1 holder's latest filing reports 5% or more of ordinary shares, par value chf 0.05 per share. Each figure below is the holder's own, as filed, with the filing linked.

Holders

HolderPercentSharesLatestEvent date
6.2%5,318,023SCHEDULE 13D/A, 2026-11-122026-11-10
Balderton Capital VI, S.L.P.4.9%3,301,240SCHEDULE 13G/A, 2026-02-112025-12-31

Holding shares or following this stake? See who's behind SOPHiA GENETICS SA and the warning signs.

Free to see. No signup.

Want the whole picture on SOPHiA GENETICS SA?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on SOPHiA GENETICS SA: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on SOPHiA GENETICS SA covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Voting and dispositive power, as filed

Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Schindel Yair Chaim05,318,02305,318,023SCHEDULE 13D/A, 2026-11-12
aMoon Growth Fund Limited Partnership05,318,02305,318,023SCHEDULE 13D/A, 2026-11-12
aMoon Growth Fund G.P. Limited Partnership05,318,02305,318,023SCHEDULE 13D/A, 2026-11-12
aMoon General Partner Ltd.05,318,02305,318,023SCHEDULE 13D/A, 2026-11-12
aMoon Edge Limited Partnership0000SCHEDULE 13D/A, 2026-11-12
aMoon Edge GP Ltd.0000SCHEDULE 13D/A, 2026-11-12
Hilliyon Holdings Ltd.0000SCHEDULE 13D/A, 2026-11-12
Berko Capital Ltd.0000SCHEDULE 13D/A, 2026-11-12
Dr. Tomer Berkovitz0000SCHEDULE 13D/A, 2026-11-12

The latest filing identifies SOPHiA GENETICS SA by CUSIP H82027105 and gives its principal executive office as LA PIECE, CH-1180, ROLLE (SCHEDULE 13D/A, 2026-11-12).

Purpose of Transaction (Item 4)

Schindel Yair Chaim

On November 10, 2026, aMoon Edge sold an aggregate of 192,541 Ordinary Shares in a private block sale at a price of $7.70 per share for gross proceeds of approximately $1.48 million.Item 4 of the SCHEDULE 13D/A filed 2026-11-12

Timeline

FiledHolderPercentFiling
2026-02-11Balderton Capital VI, S.L.P.4.9%SCHEDULE 13G/A
2026-11-12Schindel Yair Chaim6.2%SCHEDULE 13D/A

Questions about who owns SOPHiA GENETICS SA

Who owns SOPHiA GENETICS SA?

On this page, one holder's latest ownership filing reports 5% or more of SOPHiA GENETICS SA: Schindel Yair Chaim (6.2%, Schedule 13D/A, filed 2026-11-12).

When did Schindel Yair Chaim buy into SOPHiA GENETICS SA?

The filings give report dates, not purchase dates. The earliest filing from Schindel Yair Chaim on this page is the Schedule 13D/A, filed 2026-11-12, reporting 6.2%. That earliest filing is itself an amendment, which updates an earlier report.

Is this an audit or a full list?

Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 2 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.

Tools for this story

Each opens in a new tab, filled in for SOPHiA GENETICS SA. With no account yet, you sign up free and land on the result.

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

Cite this page

Permanent URL: https://mentionfox.com/stakes/sophia-genetics-sa
Last updated 2026-11-13
Primary record: SEC filing 1 · SEC filing 2
Who owns 5% or more of SOPHiA GENETICS SA? 1 holder at 5% or more, largest Schindel Yair Chaim 6.2%. MentionFox, 2026-11-13. https://mentionfox.com/stakes/sophia-genetics-sa